Tigecycline
Active substance: tigecycline
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TIGECYCLINE 50 mg/5mL
United StatesActive
Marketing holder: Meitheal Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- TIGECYCLINE · 50 mg/5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 3 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-41ad-7b6e-9b11-f0f0d73305fc,01a12090-c2dc-71f5-8f7b-b024969dbf06,01a12093-bdf9-7820-98ef-84731bbde669,01a12094-bae2-74bc-9c90-179fff2397fb,01a12095-c95f-7cf1-80d1-c0a784b2f8fe;count=7 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 71288-019
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 71288-019 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71288-019 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71288-019 · Verified 2026-10-09 · open in source